Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,165.08
(
0.80%
)
US TECH 100
26,538.40
(
1.85%
)
Dow Jones
49,247.66
(
-0.13%
)
Brent Oil
100.66
(
0.00%
)
Bitcoin
78,105.72
(
0.62%
)
News Focus
News Focus
Post# of 185011
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

stock1ace1

Send PM Follow Ignore
Followers 289
Posts 38536
Boards Moderated 2
Alias Born 04/05/2012

stock1ace1

Re: Lone Wolf post# 83896

Wednesday, 09/27/2017 8:39:28 AM

Wednesday, September 27, 2017 8:39:28 AM

Post# of 185011
Ktov + Ktovw ** Broke 200ma FDA News Watch for reaponse to phase 3 drug “kit-302” NDA filed in july !


On July 31, 2017, Kitov Pharmaceuticals Holdings Ltd. (the “Company”) announced that it had submitted a New Drug Application to the U.S. Food and Drug Administration for KIT-302, its lead drug candidate. On July 31, 2017, the Company issued a press release in connection with its submission of the New Drug Application, “ Kitov Submits New Drug Application to FDA for KIT-302 ”, which is attached hereto as Exhibit 99.1

D1sclaimer: I am not a financial advisor or a stock promoter. I am an investor, Period! Do your own DD and make your own investment decisions.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today